Although our current results suggest that CD44 is a novel PTX3 receptor and that the PTX3/CD44 complex does indeed play a vital role in the promotion of metastasis/invasion and stemness of cancer cells, we cannot rule out other potent PTX3 receptors and their involvement in tumourigenesis. The gene discussed is CD44; the disease is cancer.